The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final report of a phase I study of 2-hydroxyoleic acid (2OHOA) a novel sphingomyelin synthase activator in patients (pt) with advanced solid tumors (AST) including recurrent high grade gliomas (rHGG).
 
Analia Azaro
No Relationships to Disclose
 
Elizabeth R. Plummer
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - Astex Pharmaceuticals; AstraZeneca; Bayer; Clovis Oncology; Karus Therapeutics; Mission Therapeutics; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech; Vertex
Speakers' Bureau - Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Clovis Oncology (Inst); Eisai (Inst); Etherapeutics (Inst); Ipsen (Inst); vertex (Inst)
Patents, Royalties, Other Intellectual Property - Named on patent of use of PARP inhibitor rucaparib (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Ander Urruticoechea
Consulting or Advisory Role - Eisai
Travel, Accommodations, Expenses - Eisai; Merck; Roche
 
Jordi Rodon
Consulting or Advisory Role - Lilly; Novartis; Orion
Research Funding - Orion; Principa Biopharma
Travel, Accommodations, Expenses - MSD
 
Noor R Md Haris
No Relationships to Disclose
 
Gareth Veal
Consulting or Advisory Role - Novartis (Inst); Sanofi (Inst)
 
Antoine Perier
Stock and Other Ownership Interests - Lipopharma
Honoraria - Lipopharma
Consulting or Advisory Role - Lipopharma
 
Vicenc Tur
Employment - Lipopharma
Leadership - Lipopharma
Stock and Other Ownership Interests - Lipopharma
Honoraria - Lipopharma
 
Pablo V. Escriba
Stock and Other Ownership Interests - Lipopharma
 
Xavier Busquets
Stock and Other Ownership Interests - Lipopharma
Travel, Accommodations, Expenses - Lipopharma
 
Joan Alberti
Consulting or Advisory Role - Lipopharma
 
Elisabet Sicart
No Relationships to Disclose
 
Dearbhaile Collins
No Relationships to Disclose
 
Ricardo Fernandez
No Relationships to Disclose
 
Evelyne Bettenhaussen
Employment - SMS Oncology
 
Edwin Klumper
Leadership - Cristal Therapeutics
Stock and Other Ownership Interests - SMS Oncology
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Janssen
 
Juanita Suzanne Lopez
No Relationships to Disclose